Atlas Trials

Safety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy Subjects

Clinical trial NCT06135363 · COMPLETED

Trial details

NCT number
NCT06135363
Sponsor
Guangzhou JOYO Pharma Co., Ltd
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Idiopathic Pulmonary Fibrosis
Start date
2022-08-11
Primary completion
2023-01-14
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.